311 related articles for article (PubMed ID: 23627858)
21. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Sims-McCallum RP
Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
[No Abstract] [Full Text] [Related]
22. [Voriconazole - applications and perspectives].
Ruhnke M
Mycoses; 2002; 45 Suppl 3():42-7. PubMed ID: 12690971
[TBL] [Abstract][Full Text] [Related]
23. CNS-aspergillosis: are there new treatment options?
Schwartz S; Thiel E
Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
[TBL] [Abstract][Full Text] [Related]
24. Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
Galiger C; Brock M; Jouvion G; Savers A; Parlato M; Ibrahim-Granet O
Antimicrob Agents Chemother; 2013 Jul; 57(7):3046-59. PubMed ID: 23587947
[TBL] [Abstract][Full Text] [Related]
25. Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
Steinbach WJ
Curr Drug Targets Infect Disord; 2005 Sep; 5(3):203-10. PubMed ID: 16181140
[TBL] [Abstract][Full Text] [Related]
26. Voriconazole for candidosis: an important addition?
Graybill JR
Lancet; 2005 Oct 22-28; 366(9495):1413-4. PubMed ID: 16243074
[No Abstract] [Full Text] [Related]
27. [Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
Balwierz W
Przegl Lek; 2004; 61 Suppl 2():89-94. PubMed ID: 15686055
[TBL] [Abstract][Full Text] [Related]
28. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
29. Better hospital nutrition needed to prevent and treat Aspergillus infections.
Curtis LT
Med Mycol; 2013 Apr; 51(3):336. PubMed ID: 22957477
[No Abstract] [Full Text] [Related]
30. Echinocandins: a wealth of choice--how clinically different are they?
Zaas AK
Curr Opin Infect Dis; 2008 Aug; 21(4):426-32. PubMed ID: 18594297
[TBL] [Abstract][Full Text] [Related]
31. [Experience with voriconazole in invasive aspergillosis].
Thiel E; Schwartz S
Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Stratakos G; Zakynthinos S
Respiration; 2007; 74(6):609-10. PubMed ID: 18037812
[No Abstract] [Full Text] [Related]
33. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
34. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
[TBL] [Abstract][Full Text] [Related]
35. Combination antifungal therapy for invasive aspergillosis.
Marr KA; Boeckh M; Carter RA; Kim HW; Corey L
Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810
[TBL] [Abstract][Full Text] [Related]
36. Update on echinocandin antifungals.
Kauffman CA; Carver PL
Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
[TBL] [Abstract][Full Text] [Related]
37. Voriconazole in newborns.
Kohli V; Taneja V; Sachdev P; Joshi R
Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
[TBL] [Abstract][Full Text] [Related]
38. Voriconazole: a new triazole antifungal.
Sabo JA; Abdel-Rahman SM
Ann Pharmacother; 2000 Sep; 34(9):1032-43. PubMed ID: 10981251
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Aspergillus terreus infections: a clinical problem not yet resolved.
Pastor FJ; Guarro J
Int J Antimicrob Agents; 2014 Oct; 44(4):281-9. PubMed ID: 25190543
[TBL] [Abstract][Full Text] [Related]
40. Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Aperis G; Mylonakis E
Expert Opin Investig Drugs; 2006 Jun; 15(6):579-602. PubMed ID: 16732713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]